Xiaofei Zhu

Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design

Xiaofei Zhu, Xiaoping Ju, Yangsen Cao et al. · International Journal of Radiation Oncology*Biology*Physics · 2019 · 80 citations

Adaptive Radiotherapy, Surgical Oncology, Pancreatic Cancer +11

RETRACTION: Stereotactic body radiotherapy plus pembrolizumab and trametinib versus stereotactic body radiotherapy plus gemcitabine for locally recurrent pancreatic cancer after surgical resection: an open-label, randomised, controlled, phase 2 trial

Xiaofei Zhu, Yangsen Cao, Wenyu Liu et al. · The Lancet Oncology · 2021 · 71 citations

Surgical Oncology, Pancreatic Cancer, Radiation Therapy +9

Primary associates of mortality among dialysis patients: Trends and reassessment of Kt/V and urea reduction ratio as outcome-based measures of dialysis dose

EG Lowrie, Xiaofei Zhu, N L Lew · American Journal of Kidney Diseases · 1998 · 65 citations

Urea Reduction Ratio, Hemodialysis, Urology +13

Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study

Ting‐Shi Su, Qiu-Hua Liu, Xiaofei Zhu et al. · Radiation Oncology · 2021 · 59 citations · Full text

Regulation of pancreatic cancer microenvironment by an intelligent gemcitabine@nanogel system via in vitro 3D model for promoting therapeutic efficiency

Di Chen, Xiaofei Zhu, Wanru Tao et al. · Journal of Controlled Release · 2020 · 35 citations

Tissue Engineering, Nanomedicine, Cell-based Drug Delivery +14